Company: OCEA
Filing Date: 2025-04-08
Form Type: 10-K
Source: 0001641172-25-003155
Chunk: 2903

Company: Ocean Biomedical, Inc.
Filing Date: 2025-04-08
Form: 10-K
Item: Item 8
Chunk 2903
---
 CURRENT ASSETS: 

    Cash 
    $-  
    $4 
  
    Restricted cash 
     224  
     1,000 
  
    Prepaid expenses 
     588  
     1,105 
  
    Total current assets 
     812  
     2,109 
  
    Investment in Virion 
     90  
     3,392 
  
    TOTAL ASSETS 
    $902  
    $5,501 

    LIABILITIES AND STOCKHOLDERS’ DEFICIT 

    CURRENT LIABILITIES: 

    Accounts payable and accrued expenses 
    $15,899  
    $16,185 
  
    Accrued expenses-related party 
     601  
     946 
  
    Short-term loans, net of issuance costs 
     16,300  
     12,118 
  
    SPA Warrant 
     1,089  
     764 
  
    Total current liabilities 
     33,889  
     30,012 
  
    NON-CURRENT LIABILITIES 

    Fixed maturity consideration 
     5,573  
     4,123 
  
    Backstop put option liability 
     59,056  
     58,523 
  
    Virion contribution liability 
     -  
     3,605 
  
    Total liabilities 
     98,518  
     96,264 
  
    STOCKHOLDERS’ DEFICIT: 

    Common stock, $0.0001
par value; 300,000,000 shares authorized
as of December 31, 2024 and 2023, respectively, 34,868,628
and 34,649,046 shares issued and outstanding
as of December 31, 2024 and 2023, respectively. 
     -  
     - 
  
    Additional paid-in capital 
     107,919  
     105,292 
  
    Accumulated deficit 
     (205,535) 
     (196,055)
  
    Total stockholders’ deficit 
     (97,616) 
     (90,763)
  
    TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT 
    $902  
    $5,501 

See
accompanying notes to the consolidated financial statements

F-